Alliance Pharma Plc (APH) Ordinary 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
44.30p
45.58p
47.95p
£244.88 million
44.75p
44.30p
24.55p
9.84
1.75p (3.76%) Previous:
1.75p
1,598,496
n/a
20,000
Performance
1 week 1W | 0.22% | 1 year 1Y | 17.36% |
---|---|---|---|
1 month 1M | 1.23% | 2 years 2Y | 26.34% |
3 months 3M | 20.8% | 3 years 3Y | 55.59% |
6 months 6M | 33.24% | 5 years 5Y | 38.03% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (£m) | 180.68 | 167.42 |
Profit before tax (£m) | (48.80) | (23.05) |
Adjusted EPS (p): | 4.55 | 4.28 |
P/E ratio | 8.90 | 12.40 |
PEG | 1.50 | n/a |
EPS growth (%) | 6.00 | (33.00) |
Values are quoted in the stock's local currency: British pound
All fundamental dataRecent dividends paid or declared by Alliance Pharma Plc:
Type | Ex-div date | Payment date | Amount |
---|---|---|---|
Final | 22/06/2023 | 18/07/2023 | 1.184p |
Interim | 22/12/2022 | 19/01/2023 | 0.592p |
Final | 09/06/2022 | 07/07/2022 | 1.128p |
Interim | 16/12/2021 | 07/01/2022 | 0.563p |
Final | 10/06/2021 | 08/07/2021 | 1.074p |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual Alliance Pharma Plc dividends:
Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
---|---|---|---|
31/12/2023 | n/a | n/a | n/a |
31/12/2022 | 3.40% | 2.41 | 1.78p |
31/12/2021 | 1.60% | 3.78 | 1.69p |
31/12/2020 | 1.80% | 3.17 | 1.61p |
31/12/2019 | 0.60% | 9.50 | n/a |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyReady to invest?
Important Documents
There are no documents available for this stock.
-
Revenue, profits rise for Alliance Pharma
30 September 2024 11:01
-
Alliance Pharma flags solid rise in first-half revenue
29 July 2024 10:30
-
Alliance Pharma COO stepping down, position to be disestablished
23 July 2024 11:06
-
Notification of Major Holdings
10 October 2024 18:11
-
Interim Results
30 September 2024 07:00
-
Notification of Half Year Results
12 September 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.